Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar_老虎社区_美港股上老虎

Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar

Dow Jones2021-12-20

Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food and Drug Administration approved Yusimry, a Humira biosimilar product.

Yusimry is indicated for plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.

Approval was based on a data package that demonstrated the biosimilarity of Yusimry to the reference product, Humira.

Coherus said it plans to launch Yusimry in the U.S. on or after July 1, 2023, per the terms of an agreement with Humira manufacturer AbbVie Inc.

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

chaisiewling
·2021-12-20
Like
回复
1
举报
收起
- chaisiewling:
  Like
  2021-12-20
  回复
  举报
Junpani
·2021-12-20
Like pls
回复
1
举报
Dttk
·2021-12-20
like pls
回复
1
举报
收起
- Junpani:
  done
  2021-12-20
  回复
  举报
whoartthou
·2021-12-20
C
回复
4
举报
收起
- Dttk:
  ok
  2021-12-20
  回复
  举报
whoartthou
·2021-12-20
C
回复
5
举报
vxf
·2021-12-20
Stay invested
回复
8
举报
leslielimsh
·2021-12-20
Like pls
回复
7
举报
收起
- vxf:
  stay invested
  2021-12-20
  回复
  举报
Starlightdaz
·2021-12-20
Like pls
回复
6
举报
收起
- whoartthou:
  f
  2021-12-20
  回复
  举报
- leslielimsh:
  ok
  2021-12-20
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1189443139?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-12-20 21:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189443139","market":"us","top_or_hot":-1,"title":"Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar","media":"Dow Jones","content":"<p>Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food and Drug Administration approved Yusimry, a Humira biosimilar product.</p>\n<p>Yusimry is indicated for plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.</p>\n<p>Approval was based on a data package that demonstrated the biosimilarity of Yusimry to the reference product, Humira.</p>\n<p>Coherus said it plans to launch Yusimry in the U.S. on or after July 1, 2023, per the terms of an agreement with Humira manufacturer AbbVie Inc.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Coherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCoherus Shares Up 7.2% After FDA Approves Yusimry, Humira Biosimilar\n</h2>\n\n<h4 class=\"meta\">\n\n2021-12-20 21:56 北京时间&nbsp;&nbsp;&nbsp;<strong>Dow Jones</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food and Drug Administration approved Yusimry, a Humira biosimilar product.\nYusimry is indicated for ...</p>\n\n<a href=\"None\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CHRS","symbol_name":"Coherus Biosciences","start_time":0,"source_url":null,"article_id":"1189443139","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189443139","pubTimestamp":1640008567,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food a","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CHRS":"Coherus Biosciences"},"translate_title":"美国食品和药物管理局批准Yusimry、Humira BioLimare后，Cohorus股价上涨7.2%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CHRS":0.9},"content_text":"Coherus BioSciences Inc. shares rose 7.2%, to $17.66, premarket Monday after it said the U.S. Food and Drug Administration approved Yusimry, a Humira biosimilar product.\nYusimry is indicated for plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn's disease, and ulcerative colitis.\nApproval was based on a data package that demonstrated the biosimilarity of Yusimry to the reference product, Humira.\nCoherus said it plans to launch Yusimry in the U.S. on or after July 1, 2023, per the terms of an agreement with Humira manufacturer AbbVie Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":693630424,"gmtCreate":1640011526086,"gmtModify":1640011526308,"author":{"id":"3584578813080112","authorId":"3584578813080112","name":"chaisiewling","avatar":"https://static.tigerbbs.com/a9a4a1e448f0d39c51c24533166eb658","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693630424","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7056315,"gmtCreate":1640011534684,"gmtModify":1640011534711,"authorId":3584578813080112,"author":{"id":3584578813080112,"authorId":3584578813080112,"name":"chaisiewling","avatar":"https://static.tigerbbs.com/a9a4a1e448f0d39c51c24533166eb658","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693630424,"type":1,"supId":0,"prevId":0,"content":"Like ","text":"Like ","html":"Like "}],"langContent":"CN"},{"id":693607142,"gmtCreate":1640010669848,"gmtModify":1640010820965,"author":{"id":"3582059874598092","authorId":"3582059874598092","name":"Junpani","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693607142","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693608147,"gmtCreate":1640010056700,"gmtModify":1640010056973,"author":{"id":"3572939968720880","authorId":"3572939968720880","name":"Dttk","avatar":"https://static.tigerbbs.com/82269b01d70f98d5770f4418d3911ef9","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"like pls","listText":"like pls","text":"like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693608147","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7056075,"gmtCreate":1640010664195,"gmtModify":1640010664289,"authorId":3582059874598092,"author":{"id":3582059874598092,"authorId":3582059874598092,"name":"Junpani","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693608147,"type":1,"supId":0,"prevId":0,"content":"<u>done</u>","text":"<u>done</u>","html":"<u>done</u>"}],"langContent":"CN"},{"id":693877564,"gmtCreate":1640009632771,"gmtModify":1640009633831,"author":{"id":"3581653518216493","authorId":"3581653518216493","name":"whoartthou","avatar":"https://static.tigerbbs.com/255e220c4fd45d829d979119233c8196","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"C","listText":"C","text":"C","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693877564","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7055962,"gmtCreate":1640010061555,"gmtModify":1640010061589,"authorId":3572939968720880,"author":{"id":3572939968720880,"authorId":3572939968720880,"name":"Dttk","avatar":"https://static.tigerbbs.com/82269b01d70f98d5770f4418d3911ef9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693877564,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"CN"},{"id":693877212,"gmtCreate":1640009625493,"gmtModify":1640009626556,"author":{"id":"3581653518216493","authorId":"3581653518216493","name":"whoartthou","avatar":"https://static.tigerbbs.com/255e220c4fd45d829d979119233c8196","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"C","listText":"C","text":"C","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693877212","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693874393,"gmtCreate":1640009251092,"gmtModify":1640009252454,"author":{"id":"3582839637303229","authorId":"3582839637303229","name":"vxf","avatar":"https://static.tigerbbs.com/b1ee9a28e0a19bf5b87d52e90dc87788","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Stay invested","listText":"Stay invested","text":"Stay invested","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693874393","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":693872139,"gmtCreate":1640008865632,"gmtModify":1640008865899,"author":{"id":"3556963403184938","authorId":"3556963403184938","name":"leslielimsh","avatar":"https://static.tigerbbs.com/f9f9dcec0fcb43be1e186d36bdd2e129","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693872139","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7055787,"gmtCreate":1640009230697,"gmtModify":1640009230729,"authorId":3582839637303229,"author":{"id":3582839637303229,"authorId":3582839637303229,"name":"vxf","avatar":"https://static.tigerbbs.com/b1ee9a28e0a19bf5b87d52e90dc87788","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693872139,"type":1,"supId":0,"prevId":0,"content":"stay <u>invested</u>","text":"stay <u>invested</u>","html":"stay <u>invested</u>"}],"langContent":"CN"},{"id":693876095,"gmtCreate":1640008750534,"gmtModify":1640008750688,"author":{"id":"3576288493534856","authorId":"3576288493534856","name":"Starlightdaz","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693876095","repostId":1189443139,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":7055845,"gmtCreate":1640009600883,"gmtModify":1640009600921,"authorId":3581653518216493,"author":{"id":3581653518216493,"authorId":3581653518216493,"name":"whoartthou","avatar":"https://static.tigerbbs.com/255e220c4fd45d829d979119233c8196","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693876095,"type":1,"supId":0,"prevId":0,"content":"<u>f</u>","text":"<u>f</u>","html":"<u>f</u>"},{"id":7055744,"gmtCreate":1640008871763,"gmtModify":1640008871857,"authorId":3556963403184938,"author":{"id":3556963403184938,"authorId":3556963403184938,"name":"leslielimsh","avatar":"https://static.tigerbbs.com/f9f9dcec0fcb43be1e186d36bdd2e129","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":693876095,"type":1,"supId":0,"prevId":0,"content":"<u>ok</u>","text":"<u>ok</u>","html":"<u>ok</u>"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":29,"commentSize":8,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}